Aller au contenu principal
Fermer

Transgene Announces Financial Calendar for 2026
information fournie par Boursorama CP 04/02/2026 à 17:45

Strasbourg, France, February 4, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG) a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its financial reporting and Annual shareholders’ meeting dates for 2026:

March 24, 2026: 2025 Fiscal Year Results

April 29, 2026: First Quarter 2026 Financial Results

May 13, 2026: Annual Shareholders’ Meeting

September 24, 2026: First Half 2026 Financial Results

November 9, 2026: Third Quarter 2026 Financial Results



.../...

Valeurs associées

0,8620 EUR Euronext Paris -3,58%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

Cette liste ne contient aucune valeur.
Chargement...